Paloma Partners Management CO Abb Vie Inc. Call Options Transaction History

Paloma Partners Management CO

$1.66 Billion
Q1 2024

Call Options

19 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q1 2024 May 15, 2024	BUY	$159.82 - $182.1 $4.37 Million - $4.98 Million	27,368 Added 1710.5%	28,968 $5.28 Million
Q4 2023 Feb 14, 2024	BUY	$137.6 - $154.97 $220,160 - $247,952	1,600 New	1,600 $247,000
Q2 2023 Aug 14, 2023	BUY	$132.51 - $164.9 $516,788 - $643,110	3,900 New	3,900 $525,000
Q3 2022 Nov 14, 2022	SELL	$134.21 - $153.93 $5.42 Million - $6.22 Million	-40,400 Reduced 56.11%	31,600 $4.24 Million
Q2 2022 Aug 15, 2022	BUY	$137.62 - $174.96 $7.32 Million - $9.31 Million	53,200 Added 282.98%	72,000 $11 Million

Q1 2022 May 16, 2022	BUY	$131.98 - $163.75 $13,197 - $16,375	100 Added 0.53%	18,800 $3.05 Million
Q3 2021 Nov 15, 2021	BUY	$106.4 - $120.78 $1.49 Million - $1.69 Million	14,000 Added 297.87%	18,700 $2.02 Million
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $1.19 Million - $1.32 Million	-11,300 Reduced 70.63%	4,700 $529,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $797,940 - $878,436	7,800 Added 95.12%	16,000 $1.73 Million
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $2.73 Million - $3.21 Million	-31,800 Reduced 79.5%	8,200 $719,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $1.76 Million - $2.36 Million	24,000 Added 150.0%	40,000 $3.93 Million
Q1 2020 May 15, 2020	SELL	$64.5 - $97.79 $1.14 Million - $1.73 Million	-17,700 Reduced 52.52%	16,000 $1.22 Million
Q4 2019 Feb 14, 2020	BUY	$72.13 - $90.25 $1.8 Million - $2.25 Million	24,900 Added 282.95%	33,700 $2.98 Million
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $2.94 Million - $3.76 Million	-44,800 Reduced 83.58%	8,800 $640,000
Q1 2019 May 15, 2019	BUY	$77.14 - $90.79 $4.13 Million - $4.87 Million	53,600 New	53,600 $4.32 Million
Q4 2018 Feb 14, 2019	SELL	$77.85 - $96.01 $3.22 Million - $3.97 Million	-41,400 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$88.91 - $98.84 $2.89 Million - $3.21 Million	32,500 Added 365.17%	41,400 $3.92 Million
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $6.73 Million - $7.38 Million	-75,100 Reduced 89.4%	8,900 $861,000
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $5.87 Million - $7.49 Million	84,000	84,000 $7.46 Million

Others Institutions Holding ABBV

# of Institutions

3,652

Shares Held

1.24B

Call Options Held

15.5M

Put Options Held

11.6M

Vanguard Group Inc Valley Forge, PA

170M
Shares

$28.3 Billion
0.62% of portfolio
Black Rock Inc. New York, NY

143M
Shares

$23.7 Billion
0.61% of portfolio
State Street Corp Boston, MA

78M
Shares

$12.9 Billion
0.64% of portfolio
Jpmorgan Chase & CO New York, NY

51.3M
Shares

$8.51 Billion
0.85% of portfolio
Capital International Investors Los Angeles, CA

48.1M
Shares

$7.98 Billion
1.81% of portfolio

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $293B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Account